MYCN and neuroblastoma: Interestingly, AHCY knockdown or drug-mediated inhibition induces an increase in apoptosis specifically on MYCN-amplified neuroblast cells (Chayka et al., 2015), thus showing a specific synthetic lethality and making AHCY inhibition a promising therapeutic possibility for personalized treatment of high-risk neuroblastoma.